Renova Plus

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Renova Plus

Property Description
Active Ingredients Acetaminophen, Caffeine
Form Oral Tablet (Fixed-Dose Combination)
Pharmacological Class Non-opioid Analgesic and Antipyretic Combination
Common Use Symptomatic relief of pain and feverishness
Origin Synthetic

What Type of Medicine is Renova Plus and What is its Composition?

Renova Plus is a fixed-dose combination product classified as a non-opioid analgesic and antipyretic combination. It is an orally administered medicine consisting of two active compounds derived through synthetic processes: Acetaminophen (Paracetamol) and Caffeine. The pharmaceutical preparation is a standardized oral tablet formulated to deliver both components simultaneously. Acetaminophen is the core analgesic, recognized for its pain-relieving effects and widely available worldwide. This indicates that the primary pain relief is based on a well-established and broadly used compound. This specific two-compound formulation is recognized for its ability to deliver enhanced relief compared to Acetaminophen used alone.

The Purpose and Action of this Analgesic Combination

The general purpose of Renova Plus is the fast, symptomatic relief of various forms of pain, such as common headaches, and the reduction of feverishness. The product's functionality relies on the therapeutic synergy between its two active ingredients. Acetaminophen works by affecting the central nervous system to reduce pain signaling and regulate the body’s temperature control center. Crucially, Caffeine is included as an analgesic adjuvant, a substance that significantly boosts the pain-relieving effect of the analgesic component. This means the inclusion of caffeine makes the medicine more effective for pain relief than using Acetaminophen alone. This combined action offers a comprehensive strategy for managing acute discomfort and fever. This composition is one of several common fixed-dose combinations designed to leverage the established benefits of Caffeine in enhancing analgesic efficacy.

What side effects are possible with Renova Plus?

Possible Side Effects and Safety Information

The following information details the officially documented adverse effects and safety characteristics for Renova Plus (Acetaminophen and Caffeine fixed-dose combination), based strictly on government regulatory documents.


Official Adverse Reactions and Classifications

The safety profile is structured by frequency and the System-Organ Class (SOC) affected:

  • Common Reactions: Adverse effects most frequently documented are linked to the Caffeine component and include insomnia (difficulty sleeping), nervousness, and irritability.

  • Rare Reactions: These include acute pancreatitis and certain blood and lymphatic system disorders, such as agranulocytosis and thrombocytopenia.

  • Very Rare Reactions: Severe systemic reactions are very rare, including anaphylaxis and serious cutaneous adverse reactions (SCARs) such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).


Serious Safety Considerations

Regulatory documentation highlights critical safety concerns related to the Acetaminophen component, particularly the risk of Acute Liver Failure (Hepatotoxicity). This risk is dose-dependent and explicitly associated with exceeding the maximum recommended daily amount.

Safety Limitations and Restrictions

Official labeling defines specific restrictions on use:

  • Contraindications: The medicine is officially contraindicated in individuals with severe hepatic impairment (severe liver disease) and severe renal function impairment (severe kidney disease).
  • Exposure Pattern: An enhanced risk of caffeine-related adverse effects (e.g., palpitation, anxiety) is noted when the medicine is used concurrently with high dietary intake of caffeine (e.g., coffee, tea, certain soft drinks).
  • Specific Populations: Safety notes are provided regarding use during pregnancy (requiring medical advice) and the excretion of components into breast milk during lactation.

Overdose and Emergency Response

Overdose and When to Seek Help

Immediate medical advice must be sought in the event of a suspected Renova Plus overdose, even if the patient feels well, due to the recognized risk of delayed, serious liver damage. The toxicity profile is driven by the Acetaminophen component, which can progress to life-threatening outcomes, including acute liver failure and death. The overdose may initially present with non-specific symptoms, while later manifestations can include jaundice or pain in the upper right part of the stomach.

Overdose Manifestations Severe Outcomes Emergency Regulatory Mandates
Nausea, vomiting, sweating, abdominal pain. Delayed jaundice. Acute liver failure, acute renal insufficiency, coagulopathies. Seek emergency medical attention immediately.
Tremor, restlessness, palpitations, and anxiety, associated with the Caffeine component. Ventricular and supraventricular arrhythmias. Immediate medical advice is required even if the patient feels well.

The official management procedures involve initiating symptomatic and supportive treatment. Acetylcysteine is the documented antidote, and its administration is a critical intervention. Hospital monitoring may be required to observe for the delayed onset of toxicity, which can occur days after ingestion. Individuals with underlying liver disease and those who ingest alcohol have a documented increased risk of severe toxicity.

Therapeutic Uses of Renova Plus

What Renova Plus Treats: Main Uses and Benefits

This fixed-dose combination generally provides support that helps ease the overall symptom burden for conditions marked by heightened or disruptive discomfort. The medicine is commonly used to help with discomfort in the head, including episodic tension-type headache and the painful stages of a migraine attack.

The formulation is generally relevant for easing mild to moderate somatic pain, such as generalized myalgia (muscle aches), discomfort following minor sprains, or localized issues like toothache and recurring dysmenorrhoea. It is also applied across domains where additional symptomatic support is needed to address elevated body temperature and systemic aches associated with illnesses like the common cold or influenza.

“The combination's core support involves providing enhanced symptomatic relief that may help patients cope more steadily with acute pain fluctuations.”

The analgesic support in this combination may assist with easing the intensity of discomfort, and may provide support during difficult episodes. It contributes to improved comfort during symptomatic periods by relieving fever and the associated bodyaches.


Quick Fact: Relief for Acute Discomfort

The combination is commonly used when short-term symptomatic assistance is needed for acute episodes characterized by pain and fever and may assist with maintaining functional stability.

Eligibility and Restrictions for Use

Official Eligibility Rules and Restrictions

Renova Plus is a fixed-dose combination product whose use is governed by strict, officially documented eligibility rules pertaining to its active ingredients, Acetaminophen and Caffeine.


Populations for Whom Use is Contraindicated

Classification Population/Condition
Absolute Contraindication Patients with known Hypersensitivity to Acetaminophen, Caffeine, or any components in the tablet
Absolute Contraindication Individuals with Severe Hepatic Impairment or Severe Active Liver Disease (due to Acetaminophen)
Absolute Contraindication Individuals with Severe Renal Impairment

Age- and Status-Based Limitations

  • Pediatric Use: Use is generally not recommended or is contraindicated in children under 12 years of age, as safety and efficacy are typically not established for this combination product in this age group.
  • Pregnancy and Lactation: Use is not recommended during pregnancy or while breastfeeding due to the presence of the Caffeine component.
  • Conditional Use: Caution is required in patients with non-severe hepatic or renal impairment, underlying cardiovascular conditions, or a history of chronic heavy alcohol use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documents define the interaction profile of Renova Plus, a fixed-dose combination of Acetaminophen and Caffeine, by specifying constraints based on both active ingredients.

Documented Pharmacokinetic Interactions

Co-administration with hepatic enzyme-inducing drugs, such as Barbiturates or Phenytoin, may accelerate the metabolism of Acetaminophen, a process documented to increase the risk of toxicity, especially in overdose scenarios. The absorption of Acetaminophen is accelerated by agents like Metoclopramide and Domperidone, and conversely, it is reduced by Colestyramine, necessitating dose separation when taken together. Furthermore, agents such as Probenecid may increase the plasma concentration of Acetaminophen due to reduced clearance. For the Caffeine component, co-administration with inhibitors of the CYP1A2 enzyme, such as certain Quinolone antibiotics, may increase its plasma concentration.

Key Interaction-Related Restrictions

Mandatory co-administration restrictions apply to any medicine containing Acetaminophen to prevent exceeding the documented daily dose and the associated risk of severe liver damage. The official profile documents that chronic alcohol consumption (ge 3 drinks per day) substantially increases the risk of hepatotoxicity from the Acetaminophen component. Additionally, the prolonged use of high-dose Acetaminophen is documented to enhance the effect of Coumarin anticoagulants like Warfarin.

Mechanism of Action

How Renova Plus Works

Renova Plus utilizes a targeted, multi-domain pharmacodynamic mechanism to regulate specific physiological signaling. Its function originates from engaging molecular steps that influence cascade initiation and modify downstream pathway activity.

Modulation of Receptor-Mediated Signaling

Renova Plus acts within domains involving receptor-mediated signaling by initiating or suppressing specific signaling sequences at the cellular level. This mechanism modifies early molecular steps that shape systemic pathway activity, resulting in the localized adjustment of receptor-dependent responses.

️ Attenuation of Dysregulated Signal Transduction

The compound engages mechanisms that modulate overactive or dysregulated processes driven by distinct signaling patterns. It alters pathway signal transduction that may amplify under certain conditions. The primary consequence involves attenuation of signal amplitude and a reduction in specific mediator release or concentration.

Influence on Pathway Feedback Regulation

Renova Plus is relevant in molecular cascades characterized by multi-layered activation, specifically by influencing endogenous feedback regulation within pathways. This supports the overall adjustment of processes where selective transmitters dominate, leading to predictable downstream physiological changes consistent with its observed profile.

Dosage and Administration Information

How to Use Renova (Tretinoin Cream) 0.02% — Administration Guidelines

The correct use of the medicine is defined by a specific topical application protocol and must be part of a comprehensive sun avoidance program.

Administration Details

Guideline Official Instruction
Route of Administration Topical (to the face only)
Dosing Schedule Once daily, in the evening
Dose Amount A small pearl-sized amount (approx. 5 mm diameter)
Duration of Use Safety and efficacy are not established for use daily for greater than 52 weeks

Procedural Steps for Application

  1. Preparation: Gently wash the face with a mild soap and pat the skin dry.
  2. Waiting Period: Wait 20 to 30 minutes after washing before applying the cream.
  3. Application: Apply the small pearl-sized amount of cream lightly over the entire affected area of the face.
  4. Restrictions: Avoid contact with the eyes, ears, nostrils, angles of the nose, and mouth.
  5. Post-Application: Do not wash the face or apply any other skincare products or cosmetics for at least 1 hour after applying the cream.

Contextual Requirements

Use of the cream must be an adjunct to a comprehensive skin care and sunlight avoidance program. This program requires the mandatory use of a sunscreen with an SPF of 15 or greater and protective clothing during the day. The product is for Topical Use on the Face Only and is not for ophthalmic, oral, or intravaginal use.

Recent Clinical Evidence

Renova Plus: Recent Clinical Evidence

The research base for the two-compound formulation, Renova Plus, is primarily drawn from controlled clinical trials and scientific literature reviews. This evidence base is used in research exploring how symptoms change over time related to acute pain.


Evidence for Headaches (Tension-Type and Migraine)

The main body of evidence was studied for conditions characterized by episodic headache manifestations, including acute tension-type headache and migraine attacks. Researchers primarily relied on short-term Randomized Controlled Trials (RCTs) and systematic reviews, which explored outcomes like pain-free status and relief of associated symptoms (e.g., light sensitivity). Studies describe patterns where a specific proportion of adult participants met the measured outcomes, leading to this evidence being commonly classified as High-level.


Evidence for Other Acute Pain

Evidence for other conditions, such as post-operative dental pain, is derived from Meta-analyses that aggregate data from short-term RCTs, used in observational settings evaluating daily-life functioning. These studies examined standardized patient-reported outcomes describing perceived discomfort. Findings generally relate to the analgesic outcomes when the combination was compared to the analgesic component alone, with the overall evidence typically characterized as Moderate-level.


Research Gaps and Limitations

The primary research limitation is that long-term effects are not fully established, as follow-up durations were limited to the acute pain phase. Also, data for certain groups remain insufficient. Specifically, limited information is available for the systematic study of this dual combination in adolescent populations or older adults, and the comparative evidence is lacking regarding the often-studied triple-combination formulation.

Key Studies & References The efficacy and safety of an analgesic combination of paracetamol and caffeine in the treatment of tension-type headache: a randomized controlled trial

Frequently Asked Questions (FAQ)

Common questions about Renova Plus (FAQ)


Q: How quickly can I expect to see results after starting Renova Plus?

A: Renova Plus is an oral medicine intended for the symptomatic relief of acute pain. Official product information indicates that the analgesic component works quickly by acting on the central nervous system. The goal of the analgesic component is to provide temporary relief from acute pain. The experience of relief may vary between individuals.

Q: Can I use Renova Plus in the morning or only at night?

A: The official product labeling for the oral tablets does not restrict the time of day when the medication may be taken. The key regulatory guidance specifies a maximum daily dose that should not be exceeded over a 24-hour period. Official administration guidance should be followed regarding the frequency of use.

Q: Is it possible to develop a tolerance to Renova Plus over time?

A: Regulatory documents do not classify this product as having high potential for dependence with typical short-term use. However, regulatory documents caution that prolonged or high-dose use of products containing Acetaminophen can increase the risk of liver damage and may lead to medication-overuse headache.

Q: Is it safe to use Renova Plus during the summer months?

A: Renova Plus is an oral analgesic tablet. Regulatory labeling for the oral analgesic does not list photosensitivity (increased sensitivity to the sun) as a reported adverse effect or a specific precaution related to sun exposure.

Q: Are there different strengths of Renova Plus available?

A: Yes, official regulatory documents list specific, fixed-dose strengths for the Renova Plus oral combination tablet. These standardized strengths contain a set amount of both the Acetaminophen and the Caffeine components.

Q: Can Renova Plus be used on areas of the body other than the face?

A: Renova Plus is an orally administered tablet for systemic use (intended to affect the whole body). Since it is an orally administered tablet, it is intended for systemic use throughout the body, not for localized external application on the skin.

Q: Is it true that Renova Plus works by speeding up skin cell turnover?

A: No. The mechanism of action for the Renova Plus oral tablet involves affecting pain signals in the central nervous system and influencing the body’s temperature regulation center. It is not indicated to promote skin cell turnover.

Q: Can I use Renova Plus if I have sensitive skin?

A: Official regulatory guidance identifies hypersensitivity (a severe allergy or reaction) to Acetaminophen, Caffeine, or any components in the tablet as a reason to avoid use. This is the main caution related to skin sensitivity from the product itself.

Q: Is there any research on the effectiveness of Renova Plus for scarring?

A: Clinical studies and regulatory evidence focus on its effectiveness for acute pain and headache relief. It is not indicated or studied for the treatment of skin scarring.

Q: What should be the consistency of the cream when applying Renova Plus?

A: Renova Plus is an oral tablet for ingestion, not a topical cream. The regulatory information pertains only to the consistency of the solid tablet form.

Q: Why is it advised to use only a 'pea-sized' amount of Renova Plus?

A: The official administration instructions for Renova Plus are for the oral ingestion of a tablet. Regulatory guidance does not include instructions for the topical application of a 'pea-sized' amount of cream.

Q: Can men use Renova Plus for skin concerns?

A: Renova Plus is an analgesic intended to relieve pain and fever. Its use is not categorized differently for men, and it is not indicated for treating skin concerns.

Q: Can I use this product if I am planning to get pregnant soon?

A: The official labeling provides cautions regarding use during pregnancy due to the combination of ingredients. This information suggests that consultation with a healthcare professional is necessary when considering use while pregnant or trying to conceive.

Q: How soon after stopping breastfeeding is it safe to start Renova Plus?

A: Regulatory documents state that both active ingredients are excreted into breast milk during lactation. However, official information does not specify a minimum required waiting period after stopping breastfeeding.

Q: What happens if I stop using Renova Plus suddenly?

A: As this medicine is generally intended for short-term relief of acute pain, regulatory documents do not list specific withdrawal symptoms that occur following the cessation of typical short-term use.

Q: Does Renova Plus contain any common irritants like fragrance or alcohol?

A: Regulatory documents list all inactive ingredients and excipients of the oral tablet. Information on specific compounds, such as alcohol or fragrances, is available in the official prescribing information.

Q: Are there any reports of mood changes associated with topical Renova Plus use?

A: Common adverse reactions reported in regulatory documents for the oral tablet include nervousness and irritability. These mood-related effects are generally associated with the stimulant properties of the Caffeine component in the medicine.

Q: Does alcohol consumption affect the effectiveness of topical Renova Plus?

A: Official warnings about alcohol use highlight the increased risk of severe liver damage (hepatotoxicity) when the Acetaminophen component is taken concurrently with chronic heavy alcohol consumption. The regulatory focus is on this safety risk, rather than on the direct impact on the medicine's effectiveness.

Q: Is the effect of Renova Plus temporary or permanent?

A: The product is officially indicated for the symptomatic relief of acute pain and feverishness. This indicates that the analgesic effect is temporary and lasts for the duration the medicine is active in the body.

How should Renova Plus be stored and disposed of?

How to Store and Dispose of Renova Plus?

The storage of Renova Plus (Acetaminophen and Caffeine oral tablets) must adhere to specific controlled environmental requirements to maintain the product's quality.


Official Storage Conditions

Storage Requirement Details
Temperature Store at controlled room temperature, generally 20 C to 25 C (68 F to 77 F).
Environmental Protection The tablets must be protected from moisture and light. Do not store in the bathroom or areas with excess heat.
Prohibited Environments It is required to keep the medicine from freezing and to not refrigerate the product.
Container The tablets should be stored in their original, tightly closed container.

Disposal and Child Safety

Official labeling requires that all medicine must be stored out of the sight and reach of children.

Unused or expired Renova Plus must be disposed of according to local pharmaceutical waste regulations. The recommended method is utilizing a drug take-back program. If this is unavailable, the product should be mixed with an undesirable substance and sealed before being placed in the household trash; do not flush down a sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Renova Plus found in:

A-Z Index: